Categories

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch

Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of its Insulin Glargine (Insulin glargineyfgn) Injection, 100 units/mL (U-100), which is packaged in a 10 mL vial that is inside a carton. This product is not the branded Semglee vial but the unbranded Insulin Glargine

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-pharmaceuticals-inc-viatris-company-conducting-voluntary-nationwide-recall-one-batch-insulin

 
Categories

Tuberculosis is the leading killer of people with #HIV and a major contributor to antimicrobial resistance 💊 Learn how collaboration

Tuberculosis is the leading killer of people with #HIV and a major contributor to antimicrobial resistance 💊

Learn how collaboration 🤝, action, and accountability across sectors can help bring an end to #TB 👉🏼 paho.org/en/campaigns/w…

Invest to End TB. Save Lives https://t.co/YhLrwhNMNt